Tianjin Medical University General Hospital
Tianjin, China
Location status: Recruiting
NCT Number: NCT07084701
This Effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on Memory and Cognitive Function in Adults with Sleep deprivation: A Proof-of-Concept Study aims to investigate the effects of Non-Invasive Superficial Craniocervical Lymphatic Drainage (NSCLD) on memory and cognitive function in adults experiencing sleep deprivation(SD). Given the known impact of SD on cognitive performance, this study seeks to explore whether NSCLD, as a non-invasive intervention, can mitigate the cognitive impairments associated with SD.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Tianjin, China
Location status: Recruiting
Sleep deprivation (SD) is widespread in modern society, particularly among medical students, residents, and individuals in high-stress occupations. Numerous studies have demonstrated that acute sleep deprivation significantly impairs cognitive processes such as attention, working memory, and executive function. Even short-term cognitive impairment can have serious consequences, including impaired judgment, slowed reaction times, and increased error rates.
Currently, interventions targeting cognitive decline following sleep deprivation are limited. Common strategies primarily include medications (such as caffeine and modafinil) and restorative sleep. However, these methods have limitations in both clinical and real-life settings: on one hand, medications may lead to tolerance and side effects, and on the other hand, restorative sleep often cannot reverse cognitive impairment in the short term. Therefore, developing a safe, convenient, and rapidly effective non-pharmacological intervention is of great significance.
In recent years, the glymphatic system has garnered increasing attention. This system is believed to play a key role in clearing metabolic waste from the brain, regulating sleep structure, and maintaining neurocognitive function. Superficial craniocervical lymphatic drainage (SCLD) has been proposed as a potential mechanism to improve cognitive function by enhancing the flow of cerebrospinal fluid (CSF) and lymph, reducing neuroinflammation, and minimizing the accumulation of metabolic waste.
In June 2025, a study published in Nature provided the first in vivo evidence supporting this hypothesis. Researchers applied non-invasive mechanical stimulation to the superficial lymphatic system on the skin surface of the mouse neck, resulting in a doubling of CSF drainage efficiency to cervical lymph nodes and correction of impaired brain-lymphatic efflux function in aged mice. These findings provide direct mechanistic support for the potential application of non-invasive SCLD intervention in humans.
Therefore, this study aims to establish an acute sleep deprivation model in healthy adults and explore the immediate effects of NSCLD intervention on cognitive function, with the goal of providing preliminary clinical evidence for non-pharmacological intervention strategies related to the brain-lymphatic pathway.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be randomly assigned to either an intervention group receiving NSCLD or a control group receiving a sham-intervention treatment. Cognitive function will be assessed using standardized tests before and after the intervention.
Participants will be randomly assigned to either an intervention group receiving NSCLD or a control group receiving a sham-intervention treatment. Cognitive function will be assessed using standardized tests before and after the intervention.
Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period
Evaluate memory function. 1 point for each correct string of numbers. Total score: forward score + backward score. Higher scores mean a better outcome.
Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period
The maximum score is 30 points. ≥26 points is normal. Higher scores mean a better outcome.
Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period
use Multidimensional VAS Battery. 0 points are "not at all", and 100 points are "extremely strong" (points 0- 100)
Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period
Collect blood for analysis of Aβ42/40, T-Tau, p-tau217, Plasma cortisol, Salivary α-Amylase and β-Endorphin.
Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period
Measure the power of different frequency bands of EEG and compare the changes.
Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period
Analyze the different indicators of HRV, including RMSSD, LF, HF, LF/HF ratio, SDNN, etc.
Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period
Developed by English language professionals based on TOEFL difficulty and standards, with self-compiled test papers. Full marks: 100 points. To evaluate working memory, learning memory, attention allocation, information processing speed, executive functions (such as planning and monitoring), and the retrieval and integration of long-term memory, among other aspects.
Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period
Use N-back task and Psychomotor vigilance task (PVT) ,measure metrics such as reaction time and accuracy rate.
Time frame: Day 1 (Baseline) and Day 2, repeat after a 2-week washout period
Using functional magnetic resonance imaging to evaluate brain functional activity.
Contact information is provided by the study sponsor or research team.
Tao Liu
Other
Acronym: NSCLD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06075914
Dyssomnias, Mental Disorders
Columbus, Ohio, United States
View Trial DetailsNCT07438912
Behavior, Behavioral Symptoms
Tucson, Arizona, United States
View Trial DetailsNCT05551325
Chronobiology Disorders, Circadian Rhythm Sleep Disorder, Unspecified
New Haven, Connecticut, United States
View Trial DetailsNCT06679543
Dyssomnias, Mental Disorders
Guelph, Ontario, Canada
View Trial Details